Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

KKR Gelecekteki Büyüme

Future kriter kontrolleri 2/6

KKR'in gelirinin yıllık 32.5% oranında azalacağı tahmin edilirken, yıllık kazancının yıllık 18.6% oranında artması beklenmektedir. EPS'nin yılda 19.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 13.4% olacağı tahmin edilmektedir.

Anahtar bilgiler

18.6%

Kazanç büyüme oranı

19.1%

EPS büyüme oranı

Capital Markets kazanç büyümesi	14.8%
Gelir büyüme oranı	-32.5%
Gelecekteki özkaynak getirisi	13.4%
Analist kapsamı	Good
Son güncelleme	01 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

NYSE:KKR - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	11,318	6,848	7,288	N/A	4
12/31/2025	9,645	5,477	6,142	N/A	5
12/31/2024	7,324	4,154	2,340	N/A	5
6/30/2024	26,611	3,863	7,873	7,963	N/A
3/31/2024	26,064	4,040	1,864	1,967	N/A
12/31/2023	18,664	3,681	-1,602	-1,494	N/A
9/30/2023	15,280	2,761	-3,354	-3,248	N/A
6/30/2023	12,049	1,321	-6,817	-6,705	N/A
3/31/2023	6,136	-258	-8,225	-8,129	N/A
12/31/2022	5,515	-591	-5,364	-5,279	N/A
9/30/2022	7,142	-204	-8,328	-8,250	N/A
6/30/2022	12,087	895	-9,103	-9,016	N/A
3/31/2022	19,983	2,907	-6,273	-6,187	N/A
12/31/2021	24,821	4,627	-7,279	-7,177	N/A
9/30/2021	26,832	5,539	-5,489	-5,365	N/A
6/30/2021	24,426	5,455	-4,650	-4,523	N/A
3/31/2021	20,785	4,876	-4,756	-4,620	N/A
12/31/2020	8,510	1,943	-6,107	-5,954	N/A
9/30/2020	4,716	973	-6,472	-6,317	N/A
6/30/2020	1,308	166	-5,444	-5,306	N/A
3/31/2020	743	-18	-7,478	-7,245	N/A
12/31/2019	8,077	1,972	-5,890	-5,682	N/A
9/30/2019	4,733	1,064	-6,078	-5,879	N/A
6/30/2019	5,683	1,463	-6,387	-6,182	N/A
3/31/2019	5,642	1,629	-5,409	-5,293	N/A
12/31/2018	4,199	1,101	-7,712	-7,606	N/A
9/30/2018	6,476	1,660	-6,284	-6,188	N/A
6/30/2018	5,452	1,174	-6,102	-6,008	N/A
3/31/2018	4,681	899	N/A	-4,539	N/A
12/31/2017	4,999	985	N/A	-3,532	N/A
9/30/2017	4,658	990	N/A	-3,591	N/A
6/30/2017	5,255	1,188	N/A	-2,433	N/A
3/31/2017	4,476	876	N/A	-1,974	N/A
12/31/2016	2,589	287	N/A	-1,441	N/A
9/30/2016	3,546	148	N/A	-1,903	N/A
6/30/2016	1,100	-394	N/A	-1,805	N/A
3/31/2016	4,289	-112	N/A	-1,297	N/A
12/31/2015	7,213	488	N/A	385	N/A
9/30/2015	6,522	456	N/A	1,703	N/A
6/30/2015	8,876	736	N/A	621	N/A
3/31/2015	7,630	538	N/A	3,335	N/A
12/31/2014	7,655	478	N/A	1,489	N/A
9/30/2014	10,422	756	N/A	2,300	N/A
6/30/2014	11,678	871	N/A	2,106	N/A
3/31/2014	9,611	708	N/A	164	N/A
12/31/2013	9,659	691	N/A	2,578	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: KKR 'nin tahmini kazanç büyümesi (yıllık 18.6% ) tasarruf oranının ( 2.5% ) üzerindedir.

Kazançlar ve Piyasa: KKR şirketinin kazançlarının (yıllık 18.6% ) US pazarından (yıllık 15.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: KKR şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: KKR şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi bekleniyor (yılda -32.5% ).

Yüksek Büyüme Geliri: KKR şirketinin gelirinin önümüzdeki 3 yıl içinde düşmesi öngörülüyor (yılda -32.5% ).

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: KKR 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 13.4 %).

KKR Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Price target increased by 8.6% to US$132

Recent updates

KKR Reportedly to Weigh Takeover Bid for ASMPT

Brookfield Reportedly Eyes Singapore Post

Thoma Bravo, L.P. completed the acquisition of Darktrace plc (LSE:DARK) from KKR Dark Aggregator, Summit partners.

Leonard Green & Partners, L.P. entered into an agreement to acquire GeoStabilization International LLC from KKR Americas Fund XII LP, a fund managed by KKR & Co. Inc. (NYSE:KKR).

Nomura Holdings and Mizuho Financial Group Reportedly Leading Bidders for Avendus Capital

Earnings Tell The Story For KKR & Co. Inc. (NYSE:KKR)

Impilo AB and KKR Health Care Strategic Growth Fund II SCSp managed by KKR & Co. Inc. (NYSE:KKR) completed the acquisition of an unknown minority stake in Immedica Pharma from Impilo AB.

Nomura Reportedly Enters the Race to Acquire Avendus

Alkem Reportedly Joins $3 Billion Race for JB Chem as Torrent Pauses Talks

Carlyle, Mizuho & Premji Invest Reportedly Aim for Avendus

KKR & Co. Inc. (NYSE:KKR) and Mirastar Real Estate Investment Management Limited acquired Portfolio of Five Prime Logistics assets from Peel Logistics Management Limited.

KKR's Trillion-Dollar Playbook: How Shareholders Could Win Big

KKR & Co. Inc. (NYSE:KKR) acquired Kent Valley industrial building in Auburn from Blackstone Real Estate Advisors L.P for $58.4 million.

KKR Reportedly in Talks to Buy The Parking Spot in $1.4 Billion Deal

KKR, TPG Capital, Apax Partners and Other PE Firms Reportedly Eye Purchase of Sahajanand Medical Technologies

EQT Private Capital Asia agreed to acquire PropertyGuru Group Limited (NYSE:PGRU) from TPG Capital, L.P., KKR & Co. Inc. (NYSE:KKR), REA Group Limited (ASX:REA) and others for $1 billion.

KKR-Led Consortium Reportedly Starts Sale Process for Around $3.0 Billion Philippines Hospital Business

Inter Infrastructure Capital a fund managed by IKANO Fund Management SA acquired 12.25% stake in Q-Park N.V. from company's existing shareholders and KKR Global Infrastructure Investors II LP a fund managed by KKR & Co. Inc. (NYSE:KKR).

Torrent Pharma Reportedly is Said to Seek Raising $3 Billion for KKR's Stake in JB Chemicals

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

KKR European Fund VI, a fund managed by KKR & Co. Inc. (NYSE:KKR) entered into an agreement to an additional 50% stake in FGS Global Inc from WPP plc (LSE:WPP) for approximately $780 million.

Second quarter dividend of US$0.17 announced

Price target increased by 8.6% to US$132

Second quarter 2024 earnings released: EPS: US$0.75 (vs US$0.98 in 2Q 2023)

Now 22% overvalued after recent price rise

KKR & Co. Inc. Declares Dividend for the Second Quarter of 2024, Payable on August 27, 2024

Torrent Pharmaceuticals Reportedly in Talks to Acquire KKR’s Stake in JB Chemicals

General Atlantic, Other PE Funds Reportedly in Talks for Majority Stake in AIMS

KKR North America Fund XIII SCSp managed by KKR & Co. Inc. (NYSE:KKR) and Dragoneer Investment Group, LLC entered into a definitive agreement to acquire Instructure Holdings, Inc. from Thoma Bravo, L.P. and others for $3.6 billion.

A joint venture between T-Mobile US, Inc. (NasdaqGS:TMUS) and KKR & Co. Inc. (NYSE:KKR) entered into a definitive agreement to acquire MetroNet Holdings, LLC from Oak Hill Capital Management, LLC and the Cinelli family.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR & Co. Inc. (NYSE:KKR) along with Tower Bridge Infrastructure Partners LP managed by Global Infrastructure Management, LLC completed the acquisition of 40.86222% stake in Vantage Towers AG (DB:VTWR) from Vodafone GmbH.

KKR Reportedly Mulls Options for Stake in Biotage

KKR Reportedly Considers $3 Billion Sale of KITO Crosby

KKR & Co. Inc. to Report Q2, 2024 Results on Jul 31, 2024

KKR Reportedly Considers Reviving Multibillion-Dollar Sale of Goodpack

Francisco, KKR Reportedly to Consider Takeover of Instructure

KKR Asian Fund IV and KKR & Co. Inc. (NYSE:KKR) agreed to acquire unknown controlling stake in Baby Memorial Hospital Limited.

KKR: Asset Growth Justifies Its Strong Rally

Carlyle, KKR Reportedly Shortlisted to Bid for Discover's US Student Loan Portfolio

Renesas Electronics Corporation (TSE:6723) completed the acquisition of acquire Transphorm, Inc. (NasdaqCM:TGAN) from KKR & Co. Inc. (NYSE:KKR), KKR Phorm Investors L.P., KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc. and KKR Phorm Investors GP LLC.

KKR: Overvalued Due To Rapid Multiple Expansion Despite S&P 500 Entrance

KKR Reportedly Taps Morgan Stanley for Loscam Play

Ten Suitors Reportedly in Race for Loscam

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin